Evidence map›Paper›PMID 27029588›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Metabolic Reprogramming of Host Cells by Virulent Francisella tularensis for Optimal Replication and Modulation of Inflammation.

Elliott V Wyatt, Karina Diaz, Amanda J Griffin, Jed A Rasmussen, Deborah D Crane, Bradley D Jones, Catharine M Bosio

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. mBio · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. International journal of molecular sciences · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Elliott V WyattImmunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840;
Karina DiazImmunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840;ORCID 0000-0002-4215-242X
Amanda J GriffinImmunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840;
Jed A RasmussenDepartment of Microbiology, University of Iowa Carver College of Medicine, Iowa City, IA 52242;ORCID 0000-0002-4947-8246
Deborah D CraneImmunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840;
Bradley D JonesDepartment of Microbiology, University of Iowa Carver College of Medicine, Iowa City, IA 52242; Genetics Program, University of Iowa Carver College of Medicine, Iowa City, IA 52242; and Midwest Regional Center for Excellence in Biodefense and Emerging Infectious Disease Research, University of Iowa Carver College of Medicine, Iowa City, IA 52242.
Catharine M BosioImmunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840; bosioc@niaid.nih.gov.
National Institutes of Health · USUniversity of Iowa · US

Funding

Immunity to Pulmonary InfectionsZIAAI001013 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BOSIO, CATHARINE · 2009 to 2025
$18.9M
Immunity to Pneumonic TularemiaZ01AI001013 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI BOSIO, CATHARINE · 2007 to 2008
$2.8M
Intramural NIH HHS Z01 AI001013
6 · The paper itself

Abstract

A shift in macrophage metabolism from oxidative phosphorylation to aerobic glycolysis is a requirement for activation to effectively combat invading pathogens. Francisella tularensis is a facultative intracellular bacterium that causes an acute, fatal disease called tularemia. Its primary mechanism of virulence is its ability to evade and suppress inflammatory responses while replicating in the cytosol of macrophages. The means by which F. tularensis modulates macrophage activation are not fully elucidated. In this study, we demonstrate that virulent F. tularensis impairs production of inflammatory cytokines in primary macrophages by preventing their shift to aerobic glycolysis, as evidenced by the downregulation of hypoxia inducible factor 1α and failure to upregulate pfkfb3 We also show that Francisella capsule is required for this process. In addition to modulating inflammatory responses, inhibition of glycolysis in host cells is also required for early replication of virulent Francisella Taken together, our data demonstrate that metabolic reprogramming of host cells by F. tularensis is a key component of both inhibition of host defense mechanisms and replication of the bacterium.

Indexed as

Cellular ReprogrammingAnimalsBacterial CapsulesCytokinesDown-RegulationFrancisella tularensisGlycolysisHypoxia-Inducible Factor 1, alpha SubunitInflammationMacrophage ActivationMacrophagesMiceMice, Inbred C57BLPhosphofructokinase-2TularemiaVirulenceCytokinesHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitPFKFB3 protein, mousePhosphofructokinase-2

Identifiers

PMID27029588
PMCPMC4868765
OpenAlexW2314170464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.